These distinctions extend to their associated disorders, with RYR2 mutations linked to cardiac arrhythmias such as catecholaminergic polymorphic ventricular tachycardia, while RYR1 mutations are typically associated with malignant hyperthermia and muscular pathologies (13, 43, 44). This evidence concerns the gene RYR1 and Malignant hyperthermia.